// company-profile

Vanda Pharmaceuticals Inc.

VNDA
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings73Insiders12
// api This Vanda Pharmaceuticals Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 7 insiders purchased shares. Buying was led by Chrousos Phaedra.

// 90-day insight

Over the last 90 days, Vanda Pharmaceuticals Inc. insiders bought $0 across 8 transactions with no open-market sales.

  • Most active insider: Duncan Charles Cliff with 2 transactions totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of Vanda Pharmaceuticals Inc. as of 2026-03-31

— stable
Total reported AUM
$286.7M
QoQ change
+3.9%
Reporting period
2026-03-31
#1
RENAISSANCE TECHNOLOGIES LLC
CIK 1037389
$26.0M
3.8M shares
#2
STATE STREET CORP
CIK 93751
$20.8M
3.0M shares
#3
BlackRock, Inc.
CIK 2012383
$18.5M
2.7M shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 4, 2026Chrousos PhaedraVNDA
Award
41,600$0.00$0K
Jun 4, 2026DUGAN RICHARD WVNDA
Award
41,600$0.00$0K
Jun 4, 2026Duncan Charles CliffVNDA
Award
41,600$0.00$0K
Jun 4, 2026Honore TageVNDA
Award
41,600$0.00$0K
Jun 4, 2026Mitchell Stephen RayVNDA
Award
41,600$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.